RGS2 and Alzheimer disease: Furthermore, lower expression levels of RGS2 and DLGAP1 were also found in LCLs of AD patients compared with non-demented control donors, as well as in two published gene expression data sets (GSE5281 and GSE63060) of postmortem AD brain tissues and in MCI and AD patients' blood.